Another automated assay, the ARCHITECT Periostin Immunoassay, based on the principle of chemiluminescent immunoassay (CLIA) method, was developed to measure the concentration of periostin in serum and has been used in asthma patients as an anti-IL-13 therapy [99]. This evidence concerns the gene IL13 and asthma.